 |
 |
|
         |
|
We have a proven track record in achieving tangible results that enhance our clients' reputations and ensure franchise and product success in the marketplace. Here are just a few projects we have executed: We helped a global pharmaceutical company create an integrated, comprehensive pre-approval drug access plan for a promising anti-cancer compound that met the expectations of patients, professionals, and regulatory bodies around the world in record time, setting new standards for industry. For a European pharmaceutical company unfamiliar with the patient advocacy environment, we created a phased outreach plan that introduced the company and its product to key influencers on the European and national levels, generating greater awareness and increasing attention on the value of its development program. Another client was thrown into crisis when the company discontinued its drug because it underestimated demand for the drug. We provided assistance in the areas of regulatory affairs and patient and professional group relations, suggesting a limited drug access program until production could be resumed. As a result, the company came to be viewed more favorably by medical professionals and regulatory agencies. When a client discovered an important new indication for an established drug, we devised a high profile campaign on the efficacy and safety of the drug, including a program for patient-at-risk analysis and identification of advocates to help communicate the company's key messages. The company subsequently received accelerated approval from the U.S. Food and Drug Administration. When a highly anticipated compound’s clinical results proved disappointing, our recommended strategies enabled the drug's developer to avoid the spread of misinformation among advocates, patients, and physicians. We created a clinical trial recruitment plan for a global pharmaceutical company’s trial of a first-in-class therapy by assessing and engaging patient groups in key trial locations as partners to educate patients and highlight opportunities to enroll in trials. As a result, the company completed 100% target accrual on schedule and forged relationships with a broad array of patient advocates for support in the future. When a company developed its first global access program, we helped by establishing a robust multi-dimensional, longitudinal evaluation program that promoted continuous quality improvement. For a global R&D-based oncology company wishing to understand and implement social media strategies for key health constituencies, we developed a two-day Health 2.0 “listening tour” featuring leading experts and innovators from patient and consumer groups. This workshop facilitated access to leaders in social media platforms in the advocacy community and provided an informed perspective on how social media are reshaping the pharmaceutical industry. When a company needed mental health consumer support during regulatory review for an application for a new indication for a psychiatric medication, we developed a strategic plan that increased awareness among patient advocates and generated positive discussion at the time of regulatory review. We can also help your company identify, launch, and cultivate mutually beneficial partnerships with patient, consumer, and professional groups and other key product influencers to help you reach your objectives.
|
|